Zanzalintinib
- Generic Name
- Zanzalintinib
- Drug Type
- Small Molecule
- Chemical Formula
- C29H25FN4O5
- CAS Number
- 2367004-54-2
- Unique Ingredient Identifier
- KC2JC2ZA04
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- Non-small Cell Lung CancerMetastatic Castration-resistant Prostate CancerColorectal CancerUrothelial CarcinomaHepatocellular CarcinomaHead and Neck Squamous Cell CarcinomaRenal Cell CarcinomaSolid Tumor
- Interventions
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Exelixis
- Target Recruit Count
- 1274
- Registration Number
- NCT05176483
- Locations
- 🇺🇸
Exelixis Clinical Site #70, Tyler, Texas, United States
🇺🇸Exelixis Clinical Site #66, Charlottesville, Virginia, United States
🇺🇸Exelixis Clinical Site #33, Milwaukee, Wisconsin, United States
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- Renal Cell CarcinomaMetastatic Castration-resistant Prostate CancerColorectal CancerNeoplasm MalignantHormone Receptor Positive Breast Carcinoma
- Interventions
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Exelixis
- Target Recruit Count
- 325
- Registration Number
- NCT03845166
- Locations
- 🇺🇸
Exelixis Clinical Site #84, Los Angeles, California, United States
🇺🇸Exelixis Clinical Site #71, Stanford, California, United States
🇺🇸Exelixis Clinical Site #85, Bronx, New York, United States
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
Phase 1
Active, not recruiting
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Other: Radiation
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 314
- Registration Number
- NCT03337698
- Locations
- 🇺🇸
Christiana Care Health Services, Newark, Delaware, United States
🇺🇸Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley, Las Vegas, Nevada, United States
🇺🇸Columbia University Medical Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath